Terms: = Lymphoma AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3
63050 results:
1. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
Kilickap S; Ozturk A; Karadurmus N; Korkmaz T; Yumuk PF; Cicin I; Paydas S; Cilbir E; Sakalar T; Uysal M; Yesil Cinkir H; Uskent N; Demir N; Sakin A; Dursun OU; Aver B; Turhal NS; Keskin S; Tural D; Eralp Y; Bugdayci Basal F; Yasar HA; Sendur MAN; Demirci U; Cubukcu E; Karaagac M; Cakar B; Tatli AM; Yetisyigit T; Urvay S; Gursoy P; Oyan B; Turna ZH; Isikdogan A; Olmez OF; Yazici O; Cabuk D; Seker MM; Unal OU; Meydan N; Okutur SK; Tunali D; Erman M;
Medicine (Baltimore); 2024 May; 103(21):e37972. PubMed ID: 38787994
[TBL] [Abstract] [Full Text] [Related]
2. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: A case report and literature review.
Zhong Q; Yan Y; Li S
Medicine (Baltimore); 2024 May; 103(21):e38303. PubMed ID: 38787969
[TBL] [Abstract] [Full Text] [Related]
3. Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia.
Basingab FS; Alzahrani RA; Alrofaidi AA; Barefah AS; Hammad RM; Alahdal HM; Alrahimi JS; Zaher KA; Algiraigri AH; El-Daly MM; Alkarim SA; Aldahlawi AM
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785930
[TBL] [Abstract] [Full Text] [Related]
4. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
[TBL] [Abstract] [Full Text] [Related]
5. FAT1 inhibits the proliferation of DLBCL cells via increasing the m
Wang TL; Miao XJ; Shuai YR; Sun HP; Wang X; Yang M; Zhang N
Sci Rep; 2024 May; 14(1):11836. PubMed ID: 38782965
[TBL] [Abstract] [Full Text] [Related]
6. Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.
Salem AH; Menon RM
Clin Transl Sci; 2024 May; 17(5):e13807. PubMed ID: 38778732
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.
Heydari H; Iranikhah A; Ghasemi A; Mohammadbeigi A; Sadat-Mirei SA; Shams S; Kermani S
BMC Infect Dis; 2024 May; 24(1):512. PubMed ID: 38778271
[TBL] [Abstract] [Full Text] [Related]
8. CAR T-Cell Immunotherapy in Minority Patients with lymphoma.
Ghilardi G; Williamson S; Pajarillo R; Paruzzo L; Chen L; Grady C; Doucette A; Nemecek E; Gabrielli G; Barta SK; Svoboda J; Chong EA; Yelton R; Nasta SD; Landsburg DJ; Ugwuanyi O; Chen AI; Schachter L; White G; Ballard HJ; Weber E; Curley C; Porter DL; Garfall AL; Hwang WT; Guerra CE; Maziarz RT; Schuster SJ; Ruella M
NEJM Evid; 2024 Apr; 3(4):EVIDoa2300213. PubMed ID: 38776868
[TBL] [Abstract] [Full Text] [Related]
9. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
10. Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.
Carlund O; Thörn E; Osterman P; Fors M; Dernstedt A; Forsell MNE; Erlanson M; Landfors M; Degerman S; Hultdin M
Clin Epigenetics; 2024 May; 16(1):68. PubMed ID: 38773655
[TBL] [Abstract] [Full Text] [Related]
11. Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report.
Xu T; Wu L; Ye H; Luo S; Wang J
Diagn Pathol; 2024 May; 19(1):69. PubMed ID: 38773600
[TBL] [Abstract] [Full Text] [Related]
12. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
[TBL] [Abstract] [Full Text] [Related]
13. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.
Nakamura N; Jo T; Arai Y; Kitawaki T; Nishikori M; Mizumoto C; Kanda J; Yamashita K; Nagao M; Takaori-Kondo A
Clin Exp Med; 2024 May; 24(1):105. PubMed ID: 38771501
[TBL] [Abstract] [Full Text] [Related]
14. Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment.
Lougaris V; Piane FL; Cancrini C; Conti F; Tommasini A; Badolato R; Trizzino A; Zecca M; De Rosa A; Barzaghi F; Pignata C
Ital J Pediatr; 2024 May; 50(1):103. PubMed ID: 38769568
[TBL] [Abstract] [Full Text] [Related]
15. Treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin lymphoma.
McCormick BJ; Zieman D; Sluzevich JC; Alhaj Moustafa M
J Investig Med High Impact Case Rep; 2024; 12():23247096241255840. PubMed ID: 38767173
[TBL] [Abstract] [Full Text] [Related]
17. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
[TBL] [Abstract] [Full Text] [Related]
18. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
Zhou F; Du F; Wang Z; Xue M; Wu D; Chen S; He X
J Hematol Oncol; 2024 May; 17(1):34. PubMed ID: 38764055
[TBL] [Abstract] [Full Text] [Related]
19. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Risk Factors Collaborators
Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
[TBL] [Abstract] [Full Text] [Related]
20. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
[Next]